Do capillary dried blood spot concentrations of gamma-hydroxybutyric acid mirror those in venous blood? A comparative study

Drug Testing and Analysis

Volumn 7, Issue 4, 2015, Pages 336-340

  Sadones, Nele ^a   Archer, John R H ^b   Ingels, Ann Sofie M E ^a,c   Dargan, Paul I ^b,d   Wood, David M ^b,d   Wood, Michelle ^e   Neels, Hugo ^f   Lambert, Willy E ^a   Stove, Christophe P ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c National Institute for Criminalistics and Criminology   (Belgium)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e WATERS CORPORATION   (United States)

^f UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Capillary sampling; Dried blood spots (DBS); Gamma hydroxybutyric acid (GHB); Gas chromatography mass spectrometry (GC MS)

Indexed keywords

BLOOD; BLOOD VESSELS; GAS CHROMATOGRAPHY;

ACID CONCENTRATIONS; CAPILLARY SAMPLING; COMPARATIVES STUDIES; DRIED BLOOD SPOT; GAMMA-HYDROXYBUTYRIC ACID; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GASCHROMATOGRAPHY-MASS SPECTROMETRY; HYDROXYBUTYRIC ACIDS; SPOT CONCENTRATION; VENOUS BLOODS;

MASS SPECTROMETRY;

4 HYDROXYBUTYRIC ACID; 4-HYDROXYBUTYRIC ACID; HYDROXYBUTYRIC ACID;

ARTICLE; BLOOD SAMPLING; CAPILLARY BLOOD; CAPILLARY DRIED BLOOD SPOT; CLINICAL ARTICLE; COHORT ANALYSIS; DRIED BLOOD SPOT TESTING; DRUG INTOXICATION; HUMAN; INTERMETHOD COMPARISON; ION MONITORING; PRIORITY JOURNAL; VENOUS BLOOD; VENOUS DRIED BLOOD SPOT; BLOOD; COMPARATIVE STUDY; PROCEDURES; REPRODUCIBILITY;

DRIED BLOOD SPOT TESTING; HUMANS; HYDROXYBUTYRATES; REPRODUCIBILITY OF RESULTS;

EID: 84926249026     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1760     Document Type: Article

References (21)

1. S. Abanades, M. Farré, M. Segura, S. Pichini, D. Barral, R. Pacifici, M. Pellegrini, F. Fonseca, K. Langohr, R. De La Torre. Gamma-hydroxybutyrate (GHB) in humans: Pharmacodynamics and pharmacokinetics. Ann. N.Y. Acad. Sci. 2006, 1074, 559.
2. D.M. Wood, M. Nicolaou, P.I. Dargan. Epidemiology of recreational drug toxicity in a nightclub environment. Subst. Use Misuse 2009, 44, 1495.
3. D.M. Wood, S.L. Greene, P.I. Dargan. Five-year trends in self-reported recreational drugs associated with presentation to a UK emergency department with suspected drug-related toxicity. Eur. J. Emerg. Med. 2013, 20, 263.
4. R. Brennan, M.C. Van Hout. Gamma-hydroxybutyrate (GHB): A scoping review of pharmacology, toxicology, motives for use, and user groups. J. Psychoact. Drugs 2014, 46, 243.
5. A.-S.M.E. Ingels, S.M.R. Wille, N. Samyn, W.E. Lambert, C.P. Stove. Screening and confirmation methods for GHB determination in biological fluids. Anal. Bioanal. Chem. 2014, 406, 3553.
6. C.P. Stove, A.-S.M.E. Ingels, P.M.M. De Kesel, W.E. Lambert. Dried blood spots in toxicology: From the cradle to the grave? Crit. Rev. Toxicol. 2012, 42, 230.
7. N. Sadones, S. Capiau, P.M.M. De Kesel, W.E. Lambert, C.P. Stove. Spot them in the spot: Analysis of abused substances using dried blood spots. Bioanalysis 2014, 6, 2211.
8. A.-S. Ingels, W.E. Lambert, C.P. Stove. Determination of gamma-hydroxybutyric acid in dried blood spots using a simple GC-MS method with direct 'on-spot' derivatization. Anal. Bioanal. Chem. 2010, 398, 2173.
9. A.-S. Ingels, P. De Paepe, K. Anseeuw, D.K. Van Sassenbroeck, H. Neels, W.E. Lambert, C.P. Stove. Dried blood spot punches for confirmation of suspected gamma-hydroxybutyric acid intoxications: Validation of an optimized GC-MS procedure. Bioanalysis 2011, 3, 2271.
10. A.-S. Ingels, K.B. Hertegonne, W.E. Lambert, C.P. Stove. Feasibility of following up gamma-hydroxybutyric acid concentrations in sodium oxybate (Xyrem®)-treated narcoleptic patients using dried blood spot sampling at home: an exploratory study. CNS Drugs 2013, 27, 233.
11. A.A. Elian. Determination of endogenous gamma-hydroxybutyric acid (GHB) levels in antemortem urine and blood. Forensic Sci. Int. 2002, 128, 120.
12. S.P. Elliott. Gamma hydroxybutyric acid (GHB) concentrations in humans and factors affecting endogenous production. Forensic Sci. Int. 2003, 133, 9.
13. H. Andresen, N. Sprys, A. Schmoldt, A. Mueller, S. Iwersen-Bergmann. Gamma-hydroxybutyrate in urine and serum: Additional data supporting current cut-off recommendations. Forensic Sci. Int. 2010, 200, 93.
14. R.C. Baselt. Disposition of Toxic Drugs and Chemicals in Man, 9th Edn, Biomedical Publications, California, 2011.
15. A. Schröck, Y. Hari, S. König, V. Auwärter, S. Schürch, W. Weinmann. Pharmacokinetics of GHB and detection window in serum and urine after single uptake of a low dose of GBL -an experiment with two volunteers. Drug Test. Anal. 2013, 6, 363.
16. N. Shima, A. Miki, T. Kamata, M. Katagi, H. Tsuchihashi. Endogenous level and in vitro production of GHB in blood from healthy humans, and the interpretation of GHB levels detected in antemortem blood samples. J. Health Sci. 2005, 51, 147.
17. EMA Guideline on bioanalytical method validation. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf [16 April 2014].
18. K. Berankova, K. Mutnanska, M. Balikova. Gamma-hydroxybutyric acid stability and formation in blood and urine. Forensic Sci. Int. 2006, 161, 158.
19. S.S. Johansen, C.N. Windberg. Simultaneous determination of gamma-hydroxybutyrate (GHB) and its analogues (GBL, 1.4-BD, GVL) in whole blood and urine by liquid chromatography coupled to tandem mass spectrometry. J. Anal. Toxicol. 2011, 35, 8.
20. L.K. Sørensen, J.B. Hasselstrøm. A hydrophilic interaction liquid chromatography electrospray tandem mass spectrometry method for the simultaneous determination of gamma-hydroxybutyrate and its precursors in forensic whole blood. Forensic Sci. Int. 2012, 222, 352.
21. I.N. Petersen, C. Tortzen, J.L. Kristensen, D.S. Pedersen, T. Breindahl. Identification of a new metabolite of GHB: Gamma-hydroxybutyric acid glucuronide. J. Anal. Toxicol. 2013, 37, 291.